Paxlovid is Australia’s first-line COVID antiviral, but Lagevrio also prevents severe disease in over-70s
The brain’s immune cells can be triggered to slow down Alzheimer’s disease, study shows
29 November 2022Study: Emergency department visits more likely for dementia patients with interprofessional primary care team
29 November 2022Paxlovid is Australia’s first-line COVID antiviral, but Lagevrio also prevents severe disease in over-70s
Australia is experiencing the fourth wave of COVID for 2022, with the number of people hospitalized with COVID trending to levels seen in winter and ongoing high levels of deaths. New COVID waves are expected to occur every three to four months for some time.
